CO6210818A2 - Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñas - Google Patents
Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñasInfo
- Publication number
- CO6210818A2 CO6210818A2 CO09093298A CO09093298A CO6210818A2 CO 6210818 A2 CO6210818 A2 CO 6210818A2 CO 09093298 A CO09093298 A CO 09093298A CO 09093298 A CO09093298 A CO 09093298A CO 6210818 A2 CO6210818 A2 CO 6210818A2
- Authority
- CO
- Colombia
- Prior art keywords
- chitosan
- aminopolysaccharide
- physiologically acceptable
- acceptable salts
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/722—Chitin, chitosan
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
1.- Quitosano, un aminopolisacárido del quitosano y/o una de sus sales fisiológicamente aceptable para el tratamiento de enfermedades inflamatorias ungueales. 2.- Un aminopolisacárido del quitosano, de acuerdo con la reivindicación 1, que es soluble en el agua. 3.- Un aminopolisacárido del quitosano, de acuerdo con la reivindicación 2, que se caracteriza por tener un peso molecular superior a 500.000Da. 4.- Un aminopolisacárido del quitosano, de acuerdo con la reivindicación 2, que se caracteriza por tener un peso molecular desde 100.000 hasta 500.000Da. 5.- Un aminopolisacárido del quitosano, de acuerdo con la reivindicación 2, que es un hidroxialquil quitosano. 6.- Un hidroxialquil quitosano, de acuerdo con la reivindicación 5, que es un hidroxipropil quitosano. 7.- Un aminopolisacárido del quitosano, de acuerdo con la reivindicación 2, que es un carboxialquil quitosano. 8.- Quitosano, un aminopolisacárido del quitosano y/o una de sus sales fisiológicamente aceptable, de acuerdo con cualquiera de las anteriores reivindicaciones, en donde dicha enfermedad inflamatoria de la uña se selecciona entre psoriasis en las uñas, liquen plano, dermatitis atópica y alopecia areata. 9.- Quitosano, aminopolisacárido del quitosano y/o una de sus sales fisiológicamente aceptable, de acuerdo con cualquiera de las anteriores reivindicaciones, que se administra en combinación con uno o más principios activos. 10.- Quitosano, un aminopolisacárido del quitosano y/o una de sus sales fisiológicamente aceptable, de acuerdo con la reivindicación 9, donde se dice que el principio activo se selecciona entre corticosteroides, agentes queratolíticos, agentes anti-inflamatorios no esteroideos, agentes antipsoriáticos, agentes inmunosupresores, agentes antisépticos, hidratantes y/o agentes fortificadores de las uñas. 11.- Quitosano, un aminopolisacárido del quitosano y/o una de sus sales fisiológicamente aceptable, de acuerdo con la reivindicación 9, donde se dijo que el principio activo se selecciona entre betametasona, budesonide, clobetasol y sus sales; ácido salicílico, ácido benzóico y sus sales; extractos de plantas de Equisetum Arvense o Harpagophyton procumbens; diclofenaco, aspirina, ketoprofeno; calcipotriol, calcitriol; tretinoina, acitretína, tarazoteno; ciclosporina. 12.- Quitosano, un aminopolisacárido del quitosano y/o una de sus sales fisiológicamente aceptable, de acuerdo con cualquiera de las anteriores reivindicaciones, que se administra de forma tópica.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07102338A EP1958639A1 (en) | 2007-02-14 | 2007-02-14 | Use of chitosans for the treatment of nail inflammatory diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6210818A2 true CO6210818A2 (es) | 2010-10-20 |
Family
ID=38212471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO09093298A CO6210818A2 (es) | 2007-02-14 | 2009-09-02 | Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñas |
Country Status (31)
Country | Link |
---|---|
US (1) | US8906881B2 (es) |
EP (3) | EP1958639A1 (es) |
JP (3) | JP2010518139A (es) |
KR (1) | KR101468479B1 (es) |
CN (1) | CN101641103B (es) |
AR (1) | AR065317A1 (es) |
AU (1) | AU2008214695B2 (es) |
BR (1) | BRPI0807596A2 (es) |
CA (1) | CA2676259C (es) |
CL (1) | CL2008000443A1 (es) |
CO (1) | CO6210818A2 (es) |
CY (1) | CY1113822T1 (es) |
DK (1) | DK2117565T3 (es) |
EA (1) | EA019539B1 (es) |
EC (1) | ECSP099631A (es) |
ES (1) | ES2394169T3 (es) |
HK (1) | HK1132919A1 (es) |
HR (1) | HRP20120915T1 (es) |
IL (1) | IL200091A (es) |
MA (1) | MA31237B1 (es) |
ME (1) | ME00828B (es) |
MX (1) | MX2009008514A (es) |
MY (1) | MY150502A (es) |
NZ (1) | NZ578937A (es) |
PL (1) | PL2117565T3 (es) |
PT (1) | PT2117565E (es) |
RS (1) | RS52620B (es) |
SI (1) | SI2117565T1 (es) |
UA (1) | UA101151C2 (es) |
WO (1) | WO2008098871A2 (es) |
ZA (1) | ZA200904975B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2006291134C1 (en) | 2005-09-12 | 2013-08-15 | Abela Pharmaceuticals, Inc. | Systems for removing dimethyl sulfoxide (DMSO) or related compounds, or odors associated with same |
US9427419B2 (en) | 2005-09-12 | 2016-08-30 | Abela Pharmaceuticals, Inc. | Compositions comprising dimethyl sulfoxide (DMSO) |
WO2007033180A1 (en) | 2005-09-12 | 2007-03-22 | Abela Pharmaceuticals, Inc. | Materials for facilitating administration of dimethyl sulfoxide (dmso) and related compounds |
US10201490B2 (en) * | 2007-02-14 | 2019-02-12 | Polichem Sa | Use of chitosans for the treatment of nail inflammatory diseases |
MY155235A (en) * | 2009-01-08 | 2015-09-30 | Allergan Inc | Cyclosporine compositions for enhancing nail growth |
EP2493314B1 (en) | 2009-10-30 | 2020-04-08 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis |
US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
EA033767B1 (ru) * | 2014-06-10 | 2019-11-22 | Makhbuba Nabi Kyzy Velieva | Средство против выпадения волос на основе лекарственных растений |
PL233616B1 (pl) | 2017-08-10 | 2019-11-29 | Podopharm Spolka Z Ograniczona Odpowiedzialnoscia | Preparat do paznokci, dloni i stop oraz sposob wytwarzania tego preparatu |
KR102511613B1 (ko) * | 2019-09-23 | 2023-03-17 | 포항공과대학교 산학협력단 | 키토산을 포함하는 면역억제용 조성물 및 이의 용도 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE378109B (es) | 1972-05-19 | 1975-08-18 | Bofors Ab | |
DE3541305A1 (de) | 1985-11-22 | 1987-05-27 | Wella Ag | Kosmetische mittel auf der basis von n-hydroxypropylchitosanen, neue n-hydroxypropyl-chitosane sowie verfahren zu ihrer herstellung |
JPH08245401A (ja) * | 1995-03-14 | 1996-09-24 | Osamu Hatanaka | 皮膚保護剤 |
SE9604610D0 (sv) * | 1996-12-16 | 1996-12-16 | Noviscens Ab | Medical composition |
US7147854B2 (en) * | 1997-06-23 | 2006-12-12 | Yes Biotech Laboratories Ltd. | Topical treatment of psoriasis using neutralizing antibodies to interleukin-8 |
JP4185173B2 (ja) | 1997-08-07 | 2008-11-26 | 株式会社ノエビア | 両親媒性キトサン誘導体及びこれを含有する皮膚外用剤 |
US6740326B1 (en) * | 1998-09-10 | 2004-05-25 | Bioequal Ag | Topical nail care compositions |
DE19911056B9 (de) * | 1999-03-12 | 2005-09-08 | Biotec Asa | Kosmetische Zubereitungen und deren Verwendung |
JP2001055335A (ja) * | 1999-08-18 | 2001-02-27 | Toshio Sato | アレルギー性皮膚疾患治療剤 |
JP2001131030A (ja) * | 1999-11-08 | 2001-05-15 | Kureha Chem Ind Co Ltd | 発毛促進剤 |
DE10035991A1 (de) | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
NO310176B1 (no) | 2000-11-13 | 2001-06-05 | Wadlund As | Sammensetning for hud som inneholder kitosan-konjugert CLA og kitosankonjugert vitamin A eller et <beta>-cyklodekstrin-konjugertvitamin A samt fremgangsmåte for fremstilling og anvendelse avdenne |
KR20020048534A (ko) | 2000-12-18 | 2002-06-24 | 안병로 | 파라핀 왁스를 유효성분으로 하는 피부 맛사지 팩제 |
SE0100166D0 (sv) | 2001-01-22 | 2001-01-22 | Tacton Systems Ab | Configuration system |
KR100457546B1 (ko) | 2001-05-02 | 2004-11-18 | 주식회사 바이오프로젠 | 폴리프럭토오스 또는 그 유도체를 이용한 미소구 및 그제조방법 |
GB0126923D0 (en) | 2001-11-09 | 2002-01-02 | Procter & Gamble | Chitosan compositions |
WO2003051376A1 (en) * | 2001-12-14 | 2003-06-26 | Ism Biopolymer Inc. | Chitosan oligosaccharides and uses thereof |
KR100470753B1 (ko) * | 2003-01-09 | 2005-03-10 | 주식회사 자광 | 수용성 천연필름과 그의 제조방법 |
JP2004231604A (ja) | 2003-01-31 | 2004-08-19 | Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai | 担体シートおよび徐放性製剤ならびにそれらの製法 |
EP1491202A1 (en) * | 2003-06-23 | 2004-12-29 | Polichem S.A. | Nail restructuring compositions for topical application |
US20050112151A1 (en) | 2003-11-20 | 2005-05-26 | Horng Liou L. | Skin adherent hydrogels |
RU2258516C1 (ru) * | 2004-01-20 | 2005-08-20 | Государственное Образовательное Учреждение "Красноярская Государственная Медицинская Академия Министерства Здравоохранения Российской Федерации" | Способ лечения красного плоского лишая |
JP2005306746A (ja) | 2004-04-19 | 2005-11-04 | Jiyugaoka Clinic | 顔面用シワ治療剤 |
US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
JP4804770B2 (ja) * | 2005-02-28 | 2011-11-02 | 株式会社アリミノ | ヘアーコンディショニング剤およびその使用方法 |
EP1874320A1 (en) * | 2005-04-19 | 2008-01-09 | Galderma S.A. | Composition of film-forming solution type, comprising vitamin d or a derivative thereof and a corticosteroid, and use thereof in dermatology |
SI1917218T1 (sl) | 2005-06-14 | 2017-12-29 | Genis Hf. | Sestavki delno deacetiliranih hitinskih derivatov |
FR2892023B1 (fr) * | 2005-10-14 | 2009-09-25 | Galderma Sa | Composition pharmaceutique a base d'amorolfine et d'agent filmogene hydrosoluble pour application ungueale et peri-ungueale |
EP1842545A1 (en) * | 2006-04-04 | 2007-10-10 | Marinomed Biotechnologie GmbH | Anti-inflammatory polymer |
DE102006049585A1 (de) | 2006-10-22 | 2008-04-24 | Susilo, Rudy, Dr. | Nagellack für kosmetische und medizinische Anwendungen |
-
2007
- 2007-02-14 EP EP07102338A patent/EP1958639A1/en not_active Withdrawn
-
2008
- 2008-02-07 EP EP08735410A patent/EP2117565B1/en active Active
- 2008-02-07 PL PL08735410T patent/PL2117565T3/pl unknown
- 2008-02-07 WO PCT/EP2008/051479 patent/WO2008098871A2/en active Application Filing
- 2008-02-07 EP EP12155609A patent/EP2455086A1/en not_active Withdrawn
- 2008-02-07 ES ES08735410T patent/ES2394169T3/es active Active
- 2008-02-07 JP JP2009549396A patent/JP2010518139A/ja active Pending
- 2008-02-07 NZ NZ578937A patent/NZ578937A/en not_active IP Right Cessation
- 2008-02-07 BR BRPI0807596-4A patent/BRPI0807596A2/pt not_active Application Discontinuation
- 2008-02-07 KR KR1020097018463A patent/KR101468479B1/ko active IP Right Grant
- 2008-02-07 CA CA2676259A patent/CA2676259C/en not_active Expired - Fee Related
- 2008-02-07 SI SI200830843T patent/SI2117565T1/sl unknown
- 2008-02-07 RS RS20120575A patent/RS52620B/en unknown
- 2008-02-07 US US12/449,540 patent/US8906881B2/en not_active Expired - Fee Related
- 2008-02-07 MX MX2009008514A patent/MX2009008514A/es active IP Right Grant
- 2008-02-07 PT PT87354106T patent/PT2117565E/pt unknown
- 2008-02-07 DK DK08735410.6T patent/DK2117565T3/da active
- 2008-02-07 AU AU2008214695A patent/AU2008214695B2/en not_active Ceased
- 2008-02-07 UA UAA200908421A patent/UA101151C2/ru unknown
- 2008-02-07 ME MEP-2009-268A patent/ME00828B/me unknown
- 2008-02-07 CN CN2008800050836A patent/CN101641103B/zh not_active Expired - Fee Related
- 2008-02-07 EA EA200901113A patent/EA019539B1/ru not_active IP Right Cessation
- 2008-02-07 MY MYPI20093346 patent/MY150502A/en unknown
- 2008-02-07 ZA ZA200904975A patent/ZA200904975B/xx unknown
- 2008-02-12 AR ARP080100603A patent/AR065317A1/es not_active Application Discontinuation
- 2008-02-12 CL CL200800443A patent/CL2008000443A1/es unknown
-
2009
- 2009-07-27 IL IL200091A patent/IL200091A/en active IP Right Grant
- 2009-09-02 CO CO09093298A patent/CO6210818A2/es not_active Application Discontinuation
- 2009-09-04 MA MA32201A patent/MA31237B1/fr unknown
- 2009-09-14 EC EC2009009631A patent/ECSP099631A/es unknown
- 2009-11-27 HK HK09111084.5A patent/HK1132919A1/xx not_active IP Right Cessation
-
2012
- 2012-11-13 HR HRP20120915AT patent/HRP20120915T1/hr unknown
-
2013
- 2013-01-14 CY CY20131100040T patent/CY1113822T1/el unknown
-
2014
- 2014-08-08 JP JP2014162698A patent/JP6035292B2/ja not_active Expired - Fee Related
-
2016
- 2016-08-05 JP JP2016155046A patent/JP2016188252A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6210818A2 (es) | Composiciones que comprenden quitosanos para el tratamiento de enfermedades inflamatorias de las uñas | |
JP2010518139A5 (es) | ||
CL2019000431A1 (es) | Tetrahidro-pirido[3,4-b]indoles moduladores de receptores de estrógenos y usos de los mismos. (divisional solicitud 201700814) | |
BR112013002601A2 (pt) | corticosteróides para o tratamento de dor em articulação | |
BR112013016661A2 (pt) | emulsões de o/a compreendendo alcanos semifluorados | |
CO6150136A2 (es) | Combinacion de adapaleno y peroxido de benzoilo para tratar lesiones de acne | |
AR065316A1 (es) | Uso de quitosanos, derivados de quitosanos y una sal fisiologiamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales | |
AR097329A1 (es) | Reducción de la deriva del rociado | |
CO6300927A2 (es) | Sales de arginina y un cation, productos de cuidado oral y personal que los contienen y metodos para preparar dichas sales y productos | |
MX366773B (es) | Composicion topica para lavado para su uso en pacientes con acne. | |
ECSP13012618A (es) | Derivados de 2,3-dihidroimidazo[1,2-c]quinazolina sustituidos con aminoalcoholes que son de utilidad para tratar trastornos hiperproliferativos y enfermedades asociadas a la angiogénesis | |
CL2012000446A1 (es) | Uso de una formulación vesicular tópica que comprende uno o más fosfolípidos y uno o más tensoactivos en una razón molar de 1:1 a 25:1 de fosfolípidos a tensoactivos, para el tratamiento de trastornos dermatosos inflamatorios. | |
PA8629501A1 (es) | Tabletas dispersables que comprenden un derivado de acido benzoico | |
GT201400069A (es) | Composiciones farmaceuticas | |
BR112012026223A2 (pt) | formulação adequada para o uso em ração animal, uso, e ração para animais. | |
BR112014009242A8 (pt) | nanossuspensão farmacêutica | |
DOP2010000135A (es) | Acido 4-[4-(2-adamantilcarbamoil)-5-tert-butilpirazol-1-il]benzoico-465 | |
AR084197A1 (es) | Composicion para uso topico para el tratamiento de trastornos de la piel | |
NI200700031A (es) | Formulaciones de ácido hidroxamico suberoilanilida y procedimientos para la producción de las mismas | |
UY29989A1 (es) | Composiciones farmacéuticas de agentes hipnoticos de accion corta en forma de liberación modificada y los procedimientos para preparar dichas formulaciones | |
ATE505477T1 (de) | Amorphe form von (11beta,16alpha)-9-fluoro-11- | |
AR077451A1 (es) | Utilizacion de benzidamina en el tratamiento de enfermedades dependientes de p40 | |
AR086252A1 (es) | Formulacion topica que comprende dipropionato de beclometasona como ingrediente activo | |
BRPI1104515B8 (pt) | Composição cicatrizante para tratamento de lesões ulcerativas da pele | |
PE20210929A1 (es) | Composicion farmaceutica en la forma de un comprimido masticable de diosmina o de una fraccion flavonoica |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |